The regulations that were put into place on July 1, 2022, are very important regulations. They are going to change the ability of the board to bring down the price of drugs in Canada to a level that is going to be more comparable to the level of 11 other countries in the world. These are fundamentally significant regulatory changes. That's why the board wants to implement the type of guidelines that will be supportive to the value and importance of those regulations.
In doing that, they have the difficult job of drawing up—